Streetbeat News

Stock Prices

PHVS

Pharvaris (NASDAQ:PHVS) presented data on its oral treatment, deucrictibant, for hereditary angioedema (HAE) at the Bradykinin Symposium 2024. The treatment is highlighted for its use as both a prophylactic and on-demand solution for HAE attacks.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 10:51 am

AI

NVDA

QQQ

SPY

Wall Street futures are mixed as investors await jobless claims data. C3.ai's earnings disappointment pressures AI stocks, while Nvidia sees modest gains. SPY and QQQ ETFs show slight premarket movements. Analysts predict short-term market weakness but expect a post-election recovery.

Portfolio Pulse from Shanthi Rexaline

September 05, 2024 | 10:51 am

LLY

Eli Lilly's phase 3 trials for once-weekly insulin efsitora show similar A1C reduction as daily doses, potentially improving diabetes management. The trials demonstrated non-inferior A1C reduction compared to daily basal insulins, with a favorable safety profile.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 10:50 am

KFY

Korn Ferry reported Q1 2025 earnings per share of $1.18, surpassing the analyst estimate of $1.12. The company's sales were $682.761 million, exceeding the expected $663.937 million, despite a 3.33% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 10:49 am

MOV

Movado Group reported Q2 earnings per share of $0.16, missing the $0.19 estimate, but sales of $159.31M beat the $150.50M estimate. EPS decreased by 57.89% from last year, while sales slightly decreased by 0.67%.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 10:48 am

LE

Lands' End reported better-than-expected Q2 2024 results with an adjusted EPS of $(0.02), beating the $(0.11) estimate, and sales of $317.17M, surpassing the $307.41M estimate. Despite the positive surprise, sales decreased by 1.91% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 10:46 am

NIO

NIO shares rose following the release of their Q2 financial results and a positive Q3 outlook.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 10:39 am

KIRK

Kirkland's reported Q2 2024 results with a GAAP EPS of $(1.11), beating the estimate of $(1.31), and sales of $86.29M, surpassing the $84.19M estimate. Despite beating estimates, sales decreased by 3.59% compared to the previous year.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 10:33 am

EAST

Eastside Distilling, Inc. (NASDAQ:EAST) announced a merger with Beeline Financial Holdings, Inc., causing its stock to skyrocket 162% in pre-market trading. The merger includes a debt-for-equity swap and asset sale, positioning Eastside in the digital mortgage services industry.

Portfolio Pulse from Benzinga Neuro

September 05, 2024 | 10:30 am

ABEQ

ACN

IETC

JGRW

KEAT

UL

Accenture and Unilever have expanded their partnership to enhance digital operations using generative AI. This multi-year program aims to set a new industry benchmark for productivity. Unilever will leverage Accenture's GenWizard platform to scale AI applications, which have already shown significant cost savings and efficiency gains. Both companies have seen stock gains over the past year.

Portfolio Pulse from Nabaparna Bhattacharya

September 05, 2024 | 10:19 am